ProQR Therapeutics N.V. (PRQR) Insider Trading

Over the last 3 months, PRQR insiders made 5 open-market buys and 0 sales, a net purchase of $1.3M (SEC Form 4). Over the last 6 months, 37 institutions increased and 26 reduced their position (13F).

Insider Activity

Sentiment
100/100
Buys (3m)
5
Sells (3m)
0
Net (3m)
$1.3M
Insiders buying
Insider trades by month Buys Sells
Jun
Jul
Aug
Context3-month price +17.5%Institutions reducing (13F)
DateInsiderTypeSharesPrice
Aug 3, 2026de Boer Daniel Antondirector, officer: Chief Executive OfficerBuy200,000$1.77
Jul 21, 2026Filius BartdirectorBuy150,000$1.72
Jul 13, 2026de Boer Daniel Antondirector, officer: Chief Executive OfficerBuy150,000$1.74
Jul 8, 2026de Boer Daniel Antondirector, officer: Chief Executive OfficerBuy150,000$1.59
Jun 30, 2026Hinsch Gylvin LykkedirectorGrant14,595$1.42
Jun 30, 2026Filius BartdirectorBuy150,000$1.54

Source: PRQR SEC Form 4 filings, latest Aug 3, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their PRQR positions over the last 6 months (SEC Form 13F).

Increased
37
New positions
14
Reduced
26
Sold out
35
Largest moves
InstitutionActionSharesFiled
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged6.3MMay 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged6.3MFeb 17, 2026
PRIVIUM FUND MANAGEMENT B.V.Increased5.5MMay 5, 2026
ABRDN PLCIncreased3.3MApr 29, 2026
AFFINITY ASSET ADVISORS, LLCReduced2.5MFeb 13, 2026
AFFINITY ASSET ADVISORS, LLCUnchanged2.5MMay 14, 2026
SIO CAPITAL MANAGEMENT, LLCIncreased2.2MFeb 17, 2026
SIO CAPITAL MANAGEMENT, LLCReduced2.0MMay 14, 2026
DAFNA CAPITAL MANAGEMENT LLCUnchanged1.6MMay 15, 2026
DAFNA CAPITAL MANAGEMENT LLCUnchanged1.6MFeb 17, 2026
KYNAM CAPITAL MANAGEMENT, LPUnchanged1.6MMay 15, 2026
KYNAM CAPITAL MANAGEMENT, LPReduced1.6MFeb 17, 2026
IKARIAN CAPITAL, LLCUnchanged1.5MMay 15, 2026
IKARIAN CAPITAL, LLCIncreased1.5MFeb 18, 2026
MORGAN STANLEYReduced1.4MFeb 13, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.